Molly Chiaramonte

Corporate Officer/Principal presso

RP Management LLC

Finance

Consumer Services

Health Technology

Profilo

Molly Chiaramonte is currently working as the Vice President-Research & Investments at RP Management LLC since 2011.
Prior to this, she worked as a Senior Vice President-Research & Investments at Royalty Pharma Plc from 2008 to 2021.
Before that, Molly was a Research Associate at Jefferies LLC from 2006 to 2008.
She completed her undergraduate degree at Providence College and holds graduate and doctorate degrees from The University of Colorado.

Posizioni attive di Molly Chiaramonte

Società	Posizione	Inizio
RP Management LLC RP Management LLC Financial ConglomeratesFinance Provides biopharma royalty transactions services	Corporate Officer/Principal	23/11/2011

Tutte le posizioni attive di Molly Chiaramonte

Precedenti posizioni note di Molly Chiaramonte

Società	Posizione	Fine
ROYALTY PHARMA PLC	Corporate Officer/Principal	01/06/2021
Jefferies LLC Jefferies LLC Investment Banks/BrokersFinance Provides brokerage services	Analyst-Equity	30/04/2008

Vedi nel dettaglio l'esperienza di Molly Chiaramonte

Formazione di Molly Chiaramonte

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Vedi nel dettaglio l'esperienza di Molly Chiaramonte

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private	5
Jefferies LLC Jefferies LLC Investment Banks/BrokersFinance Provides brokerage services	Finance
Providence College Providence College Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
The University of Colorado The University of Colorado Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
RP Management LLC RP Management LLC Financial ConglomeratesFinance Provides biopharma royalty transactions services	Finance
Royalty Pharma Plc Royalty Pharma Plc Pharmaceuticals: MajorHealth Technology Buys and operates a portfolio of biopharmaceutical royalties	Health Technology